Press Release
- Record Q1 FY27 revenue growth of 25.3% YoY to ₹1,387.9 Cr, significantly outperforming historical 11% average.
- Management raised FY27 revenue guidance to high-teens growth with sustained ~20% EBITDA margin targets.
- High-margin Beauty & Cosmetics segment surged 23.6%, driving product mix improvement.
- Merger with Indovida India received CCI approval, on track to build a $1 billion revenue platform.
- Strong ESG/sustainability positioning (44% sustainable tube contribution, EcoVadis Platinum rating).
- Low promoter holding at 26.38% (below the 35% guardrail threshold), creating structural cap on verdict.
- PAT growth in Q1 FY27 suppressed (-1.4% YoY) due to tax rate normalization, despite 10% PBT growth.
- Sensitivity to raw material (polymer/aluminum) price spikes and currency fluctuations (e.g., Egyptian pound devaluation).
- Customer concentration risk with reliance on top global FMCG accounts.
- Promoter equity holding is low at 26.38%.
EPL Limited (EPL) - Earnings & Guidance Analysis (As of Aug 11, 2026)
1. Executive Summary & Verdict Rationale
EPL Limited delivered an exceptional Q1 FY27 performance with revenue growing 25.3% YoY to ₹1,387.9 Cr—substantially exceeding its historical 11% baseline growth rate. Management officially raised its revenue guidance to 'high-teens' for upcoming quarters while maintaining EBITDA margin guidance near 20%. The merger with Indovida India Private Limited has also cleared CCI approval.
However, per equity research guardrails, Promoter holding stands at 26.38% (<35% limit). Under mandatory rules, any company with promoter holding below 35% MUST be capped at a verdict of POSSIBLE with confidence <= 0.5. Hence, despite superior ROCE (23.0%) and re-accelerating revenue growth, the verdict is capped at POSSIBLE.
2. Ramp-Aware Catalyst & Financial Math
- TTM Revenue: ₹3,992 Cr | TTM PAT: ₹367.4 Cr | TTM EPS: ₹11.42
- Q1 FY27 Performance: Revenue ₹1,387.9 Cr (+25.3% YoY), EBITDA ₹261.2 Cr (+15.2% YoY), PBT ₹148 Cr (+10% YoY). PAT dropped 1.4% to ₹101.8 Cr due to tax rate normalization.
- Guidance & FY27 Estimate: High-teens growth (~18% top-line expansion) yields ~₹4,710 Cr in FY27 revenue. At a steady 20% EBITDA margin and normalized 25% tax rate, FY27 PAT is projected at ~₹425 Cr (EPS ~₹13.25, representing ~16% EPS growth).
3. Industry Context & Multibagger Fundamentals
- Capital Intensity & CAGR: Specialty tube packaging carries MEDIUM capital intensity. The global specialty packaging market grows at ~8-10% CAGR. EPL is gaining market share via sustainable tube formats (44% of sales) and high-value Beauty & Cosmetics (+23.6% growth).
- ROCE & Balance Sheet: ROCE is strong at 23.0%, and D/E is manageable at 0.44 (Debt ₹523 Cr vs Net worth ₹1,181 Cr). Margins have comfortably held above 20% for 7 consecutive quarters.
4. Valuation & Scenario Calibration
- Current Valuation: Share price ₹235.8 | Market Cap ₹7,585 Cr | Trailing P/E 20.6x (vs Peer median 12.7x).
- Base Case (35% upside, Target ~₹318): FY27 EPS ₹13.25 valued at 24x forward P/E as high-teens revenue growth and Indovida merger synergies materialize.
- Bull Case (65% upside, Target ~₹390): B&C share expands >55%, margin expands to 21.5%, driving FY28 EPS to ₹15.6 at 25x P/E.
- Bear Case (-15% downside, Target ~₹200): Polymer cost spikes squeeze OPM to 18%, keeping EPS flat near ₹11.4 with P/E de-rating to 17.5x.
5. Conclusion
Fundamentally, EPL shows high quality (Grade B+, ROCE 23%) and re-accelerating execution. However, the low promoter equity stake (26.38%) bounds the overall conviction rating under risk guardrails.
